Data as of Jul 22
| -0.02 / -0.90%|
The 4 analysts offering 12-month price forecasts for Antares Pharma Inc have a median target of 6.00, with a high estimate of 6.50 and a low estimate of 5.00. The median estimate represents a +171.49% increase from the last price of 2.21.
The current consensus among 4 polled investment analysts is to Buy stock in Antares Pharma Inc. This rating has held steady since July, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.